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Abstract
Background—Monitoring trends in cardiovascular events can provide key insights into the 
effectiveness of prevention efforts. Leveraging data from electronic health records provides a 
unique opportunity to examine contemporary, community-based trends in acute myocardial 
infarction hospitalizations.
Methods—We examined trends in hospitalized acute myocardial infarction incidence among 
adults aged ≥25 years in 13 U.S. health plans in the Cardiovascular Research Network. The first 
hospitalization per member for acute myocardial infarction overall and for ST-segment elevation 
myocardial infarction and non-ST-segment elevation myocardial infarction was identified by 
ICD-9 primary discharge codes in each calendar year from 2000 through 2008. Age- and sex-
adjusted incidence was calculated per 100,000 person-years using direct adjustment with 2000 
U.S. census data.
Results—Between 2000 and 2008, we identified 125,435 acute myocardial infarction 
hospitalizations. Age- and sex-adjusted incidence rates (per 100,000 person-years) of acute 
myocardial infarction declined an average 3.8%/year from 230.5 in 2000 to 168.6 in 2008. 
Incidence of ST-segment elevation myocardial infarction declined 8.7%/year from 104.3 in 2000 
to 51.7 in 2008 while incidence of non-ST-segment elevation myocardial infarction increased from 
126.1 to 129.4 between 2000 and 2004 and then declined thereafter to 116.8 in 2008. Age- and 
sex-specific incidence rates generally reflected similar patterns, with relatively larger declines in 
ST-segment elevation myocardial infarction rates in women compared with men. As compared to 
2000, the age-adjusted incidence of ST-segment elevation myocardial infarction in 2008 was 48% 
lower among men and 61% lower among women.
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Conclusions and Relevance—Among a large, diverse, multicenter community-based insured 
population, there were significant declines in incidence of hospitalized acute myocardial infarction 
and the more serious ST-segment elevation myocardial infarctions between 2000 and 2008. 
Declines in ST-segment elevation myocardial infarctions were most pronounced among women. 
While ecologic in nature, these secular declines likely reflect, at least in part, results of 
improvement in primary prevention efforts.
Keywords
Cardiovascular disease; acute myocardial infarction; epidemiology; sex differences; trends
Although death rates from coronary heart disease have declined in recent decades, coronary 
heart disease is still the leading cause of death and is an important cause of morbidity in the 
U.S. (1). Despite the enormous burden of coronary heart disease in the U.S., the changing 
epidemiology of coronary heart disease is poorly understood in the absence of an integrated, 
comprehensive, national surveillance system for coronary heart disease, which currently 
does not exist (2). Recent studies measuring acute myocardial infarction in the U.S. have 
focused on individual communities or select populations that generally have not included 
younger age groups or broad socioeconomic, geographic and racial/ethnic diversity (3–6). 
As such, the usefulness of existing estimates of acute myocardial infarction incidence, and 
temporal trends, are limited in scope.
A number of prevention efforts have been implemented over recent decades including lower 
target levels for low density lipoprotein cholesterol and blood pressure, use of 
cardioprotective medications, and anti-tobacco campaigns resulting in improved control of 
cardiovascular disease risk factors (7–11). Together with improvements in care for patients 
hospitalized with acute myocardial infarction, these efforts have led to a sustained decline in 
mortality attributed to coronary heart disease (12–14). However, the increasing prevalence of 
obesity (15,16) and diabetes (17–19) during recent decades could have opposite effects on 
changing trends in the burden of coronary heart disease (20,21). Without comprehensive 
surveillance, it is difficult to determine the overall effect of these opposing forces on the 
burden of coronary heart disease. Such data are important to understand which preventive 
measures have been successful over time and more importantly, such data reveal areas that 
merit further investigation in order to reduce the morbidity and mortality attributable to 
coronary heart disease.
We examined trends (years 2000–2008) in the annual incidence of hospitalized acute 
myocardial infarction among 11 million adults aged ≥25 years from 13 health care delivery 
systems.
METHODS
Data Source
This study included data from the Cardiovascular Research Network (CVRN) 
Cardiovascular Disease Surveillance Study, a study that compiled a broad range of clinical 
and demographic electronic health record data for individuals receiving care through health 
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care delivery systems participating in the CVRN (www.cvrn.org) who were hospitalized for 
acute myocardial infarction, stroke, or heart failure between 2000–2008 (Figure 1). Briefly, 
the CVRN was funded by the National Heart, Lung, and Blood Institute to leverage 
expertise, populations, and data sources from geographically and ethnically diverse health 
care delivery systems that participate in the Health Care Systems Research Network 
(www.hcsrn.org) (22). The research centers embedded within these systems compile their 
administrative, claims, and electronic health record data into standardized repositories. Data 
from 13 health care delivery systems were available and included in this analysis.
Identification and Characterization of Acute Myocardial Infarction
We identified hospitalizations occurring between 1996–2008 with a primary discharge 
diagnosis of acute myocardial infarction based on the International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes 410.x0 or 410.x1 from 
hospital-discharge records and billing claims for all members aged ≥25 years. We defined 
incident acute myocardial infarction events as the first hospitalization that occurred between 
2000–2008 with no prior hospitalization for acute myocardial infarction during all available 
years of look-back. Hospitalizations for acute myocardial infarction were categorized as 
either ST-segment elevation myocardial infarction using ICD-9-CM codes 410.0 to 410.6 
and 410.8 or non-ST-segment elevation myocardial infarction using ICD-9-CM codes 410.7 
and 410.9. We assigned ICD-9-CM code 410.9 as non-ST-segment elevation myocardial 
infarction based on previous research (13). Individuals experiencing an incident ST-segment 
elevation myocardial infarction and an incident non-ST-segment elevation myocardial 
infarction were included separately in corresponding analyses, but only first-ever events 
were considered in overall acute myocardial infarction incidence. Readmissions within 7 
days of a hospital discharge where the principal discharge diagnosis code of both admissions 
was 410.x were considered to be the same clinical event.
To determine the accuracy and consistency of diagnostic coding over time, we conducted 
detailed manual chart reviews consisting of 35 randomly selected acute myocardial 
infarction hospitalizations (15 presumed ST-segment elevation myocardial infarction, 15 
presumed non-ST-segment elevation myocardial infarction, and 5 indeterminate based on 
discharge diagnostic codes) at each of the study sites at 3 time points 2000–2002, 2003–
2006, and 2007–2009. Experienced chart abstractors used a standardized form to obtain 
ischemic symptoms, history of myocardial infarction, serial measures of cardiac biomarkers, 
and all electrocardiograms during the index hospitalization. We abstracted available cardiac 
biomarkers from 72 hours prior to hospital admission until discharge or death. Abstracted 
information was independently reviewed and adjudicated by 2 physicians using criteria from 
the Atherosclerosis Risk in Communities (ARIC) study that were modified by using clinical 
readings of the 12-lead electrocardiograms (23). Using the diagnosis assigned by the 
adjudication process as the gold standard, the positive predictive value was 91.2% for acute 
myocardial infarction, 67.8% for ST-segment elevation myocardial infarction, and 70.7% for 
non-ST-segment elevation myocardial infarction, with consistency across years.
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Patient Characteristics
Patient demographic characteristics, relevant medical history, and clinical data were obtained 
from health care delivery system databases. Using previously validated approaches (24–27), 
we extracted information on history of cardiovascular disease and chronic lung disease, prior 
percutaneous coronary intervention or coronary artery bypass graft, and cardiovascular 
disease risk factors occurring 4 years before cohort entry. Prescription medications known to 
lower cardiovascular disease risk or reduce the severity of the type of clinical presentation of 
coronary heart disease were extracted from outpatient pharmacy records or claims data for 
the 30 days before the acute myocardial infarction hospitalization. Length of the hospital 
stay and death within 30 days of the acute myocardial infarction hospitalization were also 
collected.
Statistical Analysis
Patient characteristics were calculated as mean and standard deviation for continuous 
variables and frequency for categorical variables by year. Differences across time in 
continuous variables were tested using linear regression, and Cochrane-Armitage tests were 
used to assess trends across time in categorical variables. Incidence rates per 100,000 
person-years were calculated for each year, overall and stratified by sex. Denominators were 
derived from health care delivery system membership composition for each year and site. 
Rates were directly standardized to the age and sex distribution of the 2000 U.S. census 
population. Standard errors and 95% confidence intervals (CIs) were estimated using the 
Poisson distribution. To evaluate temporal trends, we estimated average annual percent 
change (AAPC) and 95% CIs using log-linear Poisson models. We compared trends between 
men and women by including an interaction term between year and sex in the regression 
models. Death within 30 days was calculated using the total number of hospitalized acute 
myocardial infarctions as the denominator and the number of deaths as the numerator.
Seven of the 13 participating sites provided incidence data for all years of the study. 
Analyses were conducted including available years of data from the 13 sites and repeated 
including only data from the 7 sites with complete data. Results were similar, so only the 
overall incidence rates by study year are presented separately for both 13 sites and 7 sites; all 
other results are presented for only the 7 sites. These 7 sites represent 75% of the total 
person-time and 80% of the incident acute myocardial infarction cases from the 13 sites. 
Analyses were conducted using SAS software version 9.2 (SAS Institute., Cary, NC). This 
study was approved by the institutional review board at each participating institution.
RESULTS
Surveillance Population
A total of 125,435 patients representing 61,892,452 person-years of observation from 13 
CVRN sites were hospitalized with incident acute myocardial infarction between 2000–2008 
(100,599 patients and 46,630,193 person-years at the 7 sites with data for all years). Across 
the 13 CVRN sites, 47,400 patients (38%) presented with ST-segment elevation myocardial 
infarction and 78,035 (62%) with non-ST-segment elevation myocardial infarction; 64% of 
all acute myocardial infarction events occurred in men and 34% in members aged ≥75 years. 
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The proportion of incident acute myocardial infarctions that were classified as ST-segment 
elevation myocardial infarctions decreased from 46% in 2000 to 31% in 2008.
Compared with patients hospitalized for incident acute myocardial infarction in 2000, 
patients hospitalized in 2008 were less likely to be white or black and more likely to have 
comorbid conditions (Table 1). The mean hospital stay decreased from 4.2 days in 2000 to 
3.8 days in 2008. The use of cardioprotective medications (except platelet inhibitors) within 
30 days before the hospitalization for acute myocardial infarction all markedly increased 
over time (Figure 2). Use of these cardiac medications was more prevalent among incident 
non-ST-segment elevation myocardial infarction cases compared with ST-segment elevation 
myocardial infarction cases.
Incidence Rates of Acute Myocardial Infarction
Age- and sex-adjusted incidence rates of acute myocardial infarction per 100,000 person-
years among the 13 health care delivery systems decreased from 230.5 cases (95% CI, 226.6 
to 234.3) in 2000 to 168.6 (95% CI, 165.6 to 171.5) in 2008, a 26.9% decline (Figure 3a). 
The AAPC of hospitalized incident acute myocardial infarction was −3.8% (95% CI, −4.0 to 
−3.6; P<0.001 for linear trend). Incidence of ST-segment elevation myocardial infarction 
decreased 50.4%, from 104.3 cases (95% CI, 101.8 to 106.9) in 2000 to 51.7 cases (95% CI, 
50.1 to 53.4) in 2008 (AAPC, −8.7%; 95% CI, −9.0 to −8.3; P<0.001 for linear trend). In 
contrast, incidence of non-ST-segment elevation myocardial infarction increased from 126.1 
cases (95% CI, 123.3 to 129.0) in 2000 to 129.4 (95% CI, 126.8 to 132.1) in 2004 before 
decreasing thereafter to 116.8 cases (95% CI, 114.4 to 119.3) in 2008 (AAPC, −0.9%; 95% 
CI −1.2 to −0.6; P<0.001 for linear trend) for a decrease of 7.4% over the 9 year period. 
Similar patterns were found for acute myocardial infarction and ST-segment elevation 
myocardial infarction when restricting analyses to the 7 sites that had data for all years with 
a 27.5% decrease in acute myocardial infarction, a 52.2% decrease in ST-segment elevation 
myocardial infarction, and a 7.5% decrease in incidence of non-ST-segment elevation 
myocardial infarction over the 9-year period (Figure 3b).
Statistically significant declines in incidence of hospitalized acute myocardial infarction and 
ST-segment elevation myocardial infarction were observed among all age groups, but the 
younger age group (25–54 years) had the smallest declines relative to the older age groups 
(Table 2). Statistically significant declines in incidence of non-ST-segment elevation 
myocardial infarction were only observed among those aged ≥55 years. Incidence of non-
ST-segment elevation myocardial infarction increased among those aged 25–54 years.
Incidence of hospitalized acute myocardial infarction was higher in men than women in each 
study year (Figure 4). For men, age-adjusted incidence of hospitalized acute myocardial 
infarction (per 100,000 person-years) was 26.4% lower in 2008 (254.0 cases; 95% CI, 247.8 
to 260.1) than in 2000 (344.9 cases; 95% CI, 336.9 to 352.9), an AAPC of −3.6% (95% CI, 
−3.9 to −3.3; P<0.001 for linear trend), while the age-adjusted incidence of hospitalized 
acute myocardial infarction among women was 29.5% lower in 2008 (125.5 cases; 95% CI, 
121.4 to 129.6) than in 2000 (178.1 cases; 95% CI, 172.6 to 183.6), an AAPC of −4.2% 
(95% CI, −4.6 to −3.8; P<0.001 for linear trend) [p for interaction=0.21]. Among both men 
and women, incidence of non-ST-segment elevation myocardial infarction increased from 
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2000–2004 and declined slightly thereafter for an overall relative decrease of 7.9% in men 
and 7.0% in women over the 9 year period. In contrast to acute myocardial infarction and 
non-ST-segment elevation myocardial infarction, women experienced statistically 
significantly greater declines in incidence of ST-segment elevation myocardial infarction 
over the study period compared with men. Incidence of ST-segment elevation myocardial 
infarction decreased 47.7% among men from 160.3 cases (95% CI, 154.9 to 165.7) in 2000 
to 83.8 cases (95% CI, 80.3 to 87.4) in 2008 (AAPC, −8.0%; 95% CI, −8.4 to −7.5; P<0.001 
for linear trend) versus a decline of 60.9% among women (P for interaction <0.001), from 
74.6 cases (95% CI, 71.0 to 78.1) in 2000 to 29.2 cases (95% CI, 27.2 to 31.2) in 2008 
(AAPC, −11.0%; 95% CI, −11.7 to −10.3; P<0.001 for linear trend).
Thirty-Day Case-Fatality Rates
Short-term death rates also declined during the study period. Age- and sex-adjusted 30-day 
mortality after acute myocardial infarction decreased 38.5% from 5.7% (95% CI, 4.4 to 6.9) 
in 2000 to 3.5% (95% CI, 2.9 to 4.1) in 2008 (P<0.001 for trend) [data not shown]. This 
decrease was primarily driven by the case fatality rate for non-ST-segment elevation 
myocardial infarction, which decreased 48.0% from 5.4% (95% CI, 3.7 to 7.1) in 2000 to 
2.8% (95% CI, 2.1 to 3.5) in 2008 (P<0.001 for trend) while the case-fatality rate for ST-
segment elevation myocardial infarction decreased 16.3% from 6.0% (95% CI, 4.2 to 7.9) in 
2000 to 5.1% (95% CI, 3.9 to 6.3) in 2008 (P<0.001 for trend).
DISCUSSION
Our study demonstrated remarkable reductions in incidence of hospitalized acute myocardial 
infarction from 2000–2008 among U.S. adults aged ≥25 years. This overall decline was 
driven by major reductions in incidence of hospitalized ST-segment elevation myocardial 
infarction, which declined by more than 50% over this period. In contrast, hospitalized non-
ST-segment elevation myocardial infarction incidence increased until 2004 and declined 
only slightly thereafter. The declines in hospitalized acute myocardial infarction were found 
in all age groups and among both men and women. However, women experienced a 
significantly greater decline in incidence of ST-segment elevation myocardial infarctions 
compared with men. The 30-day mortality after acute myocardial infarction also decreased 
significantly while the use of medications with preventive and cardioprotective effects 
increased substantially.
Despite the lack of a national surveillance system to monitor trends in coronary heart 
disease, recent population-based studies in modestly-sized cohorts such as the Framingham 
Heart Study, Olmsted County (Minnesota), ARIC study, Worcester Heart Attack Study, 
Minnesota Heart Survey, and the Corpus Christi Heart project have examined trends in 
incidence of acute myocardial infarction (3–5,12,28,29). Some regional estimates from later 
periods of the 20th century indicated stable incidence of hospitalized acute myocardial 
infarction (30,31). More recently, however, incidence of hospitalized acute myocardial 
infarction is declining, perhaps at an accelerated rate. In our 9-year period of observation, 
incidence of hospitalized acute myocardial infarction declined by 27%. By comparison, 
acute myocardial infarction incidence declined by a similar 25% in the Worcester Heart 
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Attack Study, but that decline occurred over 30 years from 1975–2005 (3). In Olmsted 
County, Minnesota, a 20% decline in age- and sex-adjusted incidence of hospitalized acute 
myocardial infarction identified by creatine kinase/creatine kinase-MB biomarkers was 
observed over a 20-year period from 1987–2006 (5). These previous studies have been 
limited with regards to age, racial/ethnic composition, and national breadth. Furthermore, 
few studies have characterized trends in incidence of ST-segment elevation myocardial 
infarctions and non-ST-segment elevation myocardial infarctions separately, as in the current 
study.
Understanding the specific reasons for the observed declines in incidence of hospitalized 
episodes of acute myocardial infarction requires additional study. We speculate that the 
widespread improvements in awareness, treatment, and control of cardiovascular disease risk 
factors that have occurred over recent decades have likely started to yield considerable 
influence on the declining incidence of hospitalized acute myocardial infarction, particularly 
incidence of hospitalized ST-segment elevation myocardial infarction (20). We documented 
a substantial increase in use of outpatient cardioprotective medications from 2000–2008. 
Although comorbid conditions increased over the study period, the increase is possibly due 
to better coding practices or increased screening over time. However, an increase in the 
prevalence of obesity, diabetes, and hypertension, may have led to the small decline in 
hospitalized acute myocardial infarction and ST-segment elevation myocardial infarction 
incidence and increase in hospitalized non-ST-segment elevation myocardial infarction 
incidence among those aged 25–54 years. It is also possible that the modest decline in 
incidence of hospitalized non-ST-segment elevation myocardial infarction that we observed 
may reflect the increasing sensitivity of cardiac biomarkers more recently, resulting in the 
detection of smaller, previously unrecognized infarctions (32). The observed increase in 
non-ST-segment elevation myocardial infarction incidence from 2000–2004, which mirrors 
the widespread increase in troponin testing, supports this hypothesis.
Similar to the results of other studies (5,33,34), incidence of hospitalized acute myocardial 
infarction was higher for men compared to women during each year of our study. However, 
in our study, women experienced significantly greater declines in incidence of ST-segment 
elevation myocardial infarction when compared to men. Few studies have examined long-
term sex specific trends by type of acute myocardial infarction. The ARIC study reported a 
5.4% and 4.4% decline/year in ST-segment elevation myocardial infarction incidence for 
men and women, respectively, between 1987–2008 (12). However, the declines were much 
larger in the period 1997–2008. For men, ST-segment elevation myocardial infarction 
incidence declined an average of 8.4%/year between 1997–2008 versus 3.0%/year between 
1987–1996. For women, ST-segment elevation myocardial infarction incidence declined 
6.9%/year between 1997–2008 versus 2.2%/year between 1987–1996 (12). The greater 
declines we observed in women could be due to better awareness of coronary heart disease 
among women during recent years due to national public education campaigns introduced in 
the early 2000s geared towards women or improved screening for and treatment of 
cardiovascular disease risk factors in women (35–37). Future studies that explore reasons 
underlying these sex-related differences in temporal trends of acute myocardial infarction 
are warranted.
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The decline in short-term death rates we observed could be the result of a shift from in-
hospital to out-of-hospital deaths due to decreased length of hospitalization and 
improvements in care. This effect may be blunted by our use of the 30-day mortality metric. 
However, our results support and extend results from previous studies and with reports of the 
overall decline of age-adjusted coronary heart disease mortality in the U.S. 
(4,5,12,28,29,38). Furthermore, in a population-based study in New England, declining 
length of stay between 1995–2005 was not associated with an increased risk of death in the 
30 and 90 days following acute myocardial infarction discharge (39).
Our study has several limitations. We did not examine out-of-hospital acute myocardial 
infarction and relied upon the accuracy and validity of electronic health record and 
administrative claims data. While our validation study showed that the positive predictive 
values of codes for ST-segment elevation myocardial infarction and non-ST-segment 
elevation myocardial infarction were not perfect, the accuracy of the codes did not differ 
significantly over time. We were unable to assess the effect of changes in diagnostic 
sensitivity with the introduction of troponins, the most sensitive biomarker of acute 
myocardial necrosis, because laboratory data were not available at many of the sites. 
However, troponin assays were already being used in the vast majority of facilities by 2000 
(12). Any bias would have likely resulted in an overestimation of incidence of acute 
myocardial infarction in the latter study years and, therefore, incidence rates of hospitalized 
acute myocardial infarction over time might have actually declined more than what we 
observed. Finally, our results may not be fully generalizable to patients in less integrated 
settings or to uninsured populations.
There are several strengths of the current study. First, this study was significantly larger than 
many other existing surveillance efforts. Second, we included community-based populations 
throughout the U.S. with broad diversity in terms of age, sex, race/ethnicity, and geography. 
Finally, few previous studies have characterized relatively contemporary trends in incidence 
of hospitalized ST-segment elevation myocardial infarction and non-ST-segment elevation 
myocardial infarction from a broad multisite perspective.
In summary, our study indicates that the community-based incidence of hospitalized acute 
myocardial infarction declined between 2000–2008, with dramatic reductions in incidence 
of the more severe ST-segment elevation myocardial infarctions, with relatively greater 
improvements observed in women. The secular trends documented in this study are 
suggestive of improvements in primary prevention efforts. Despite these advances, the 
increasing prevalence of obesity, diabetes, and hypertension could reverse these encouraging 
trends in acute myocardial infarction incidence. Therefore, continued population-based 
surveillance efforts are warranted to monitor recent trends in cardiovascular disease so that 
appropriate public health strategies can be implemented to prevent a reversal of the gains 
that have been achieved from primary and secondary prevention efforts during recent 
decades.
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Clinical Significance
• Incidence of hospitalized AMI declined from 2000–2008 among US adults 
≥25 years.
• The decline in incidence of STEMIs was more pronounced in women than 
men.
• Incidence of hospitalized NSTEMIs did not decline among younger 
individuals.
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Figure 1. 
Participating health care delivery systems in the Cardiovascular Research Network
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Figure 2. 
Use of outpatient medications prior to index hospitalization with acute myocardial infarction 
from 7 health care delivery systems in the Cardiovascular Research Network, 2000–2008
The use of medications in patients presenting with any acute myocardial infarction in Panel 
A, ST-segment elevation myocardial infarction in Panel B, and non-ST-segment elevation 
myocardial infarction in Panel C. ACE = angiotensin-converting enzyme, and ARB = 
angiotensin II-receptor blocker
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Figure 3. 
Age- and sex-adjusted incidence of acute myocardial infarction among health care delivery 
systems of the Cardiovascular Research Network, 2000–2008
Panel A includes data from 13 health care delivery systems and Panel B includes data from a 
subset of 7 health care delivery systems with data for all years of the study (p-value for trend 
<0.001 for all)
 bars represent 95% confidence intervals.
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Figure 4. 
Age-adjusted incidence of acute myocardial infarction by sex among 7 health care delivery 
systems of the Cardiovascular Research Network, 2000–2008 (p-value for trend <0.001 for 
all)
Incidence among men in Panel A and women in Panel B.
 bars represent 95% confidence intervals.
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